The groundbreaking treatment of the medication represents a major development in the care of type 2 diabetes. Different to existing therapies, tirzepatide impacts two pathways – the GLP-1 hormone and GIP – leading to enhanced sugar regulation and potential weight reduction. Experts are investigating its future effects and part in the complete d